Compare TEVA & PCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TEVA | PCG |
|---|---|---|
| Founded | 1901 | 1995 |
| Country | Israel | United States |
| Employees | 32842 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.7B | 34.3B |
| IPO Year | N/A | N/A |
| Metric | TEVA | PCG |
|---|---|---|
| Price | $29.66 | $17.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $37.38 | $21.72 |
| AVG Volume (30 Days) | 6.7M | ★ 21.2M |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.15% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.12 |
| Revenue Next Year | $2.51 | $3.46 |
| P/E Ratio | $28.19 | ★ $15.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.47 | $12.97 |
| 52 Week High | $37.35 | $19.16 |
| Indicator | TEVA | PCG |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 41.11 |
| Support Level | $28.38 | $14.52 |
| Resistance Level | $31.99 | $18.75 |
| Average True Range (ATR) | 0.99 | 0.38 |
| MACD | -0.02 | -0.19 |
| Stochastic Oscillator | 42.11 | 20.51 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision between January 2019 and June 2020. In 2004, PG&E sold its unregulated assets as part of an earlier postbankruptcy reorganization.